Paul A. Friedman

2019 - Synta Pharmaceuticals

In 2019, Paul A. Friedman earned a total compensation of $6.1M as Chairman and Chief Executive Officer at Synta Pharmaceuticals, a 8% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$387,192
Option Awards$5,122,000
Salary$584,000
Total$6,093,192

Friedman received $5.1M in option awards, accounting for 84% of the total pay in 2019.

Friedman also received $387.2K in non-equity incentive plan and $584K in salary.

Rankings

In 2019, Paul A. Friedman's compensation ranked 1,662nd out of 13,971 executives tracked by ExecPay. In other words, Friedman earned more than 88.1% of executives.

ClassificationRankingPercentile
All
1,662
out of 13,971
88th
Division
Manufacturing
593
out of 5,701
90th
Major group
Chemicals And Allied Products
180
out of 2,200
92nd
Industry group
Drugs
145
out of 1,886
92nd
Industry
Pharmaceutical Preparations
108
out of 1,398
92nd

Pay ratio

Paul A. Friedman's Pay$6,093,192
Median Employee's Pay$791,000
Pay Ratio

8

to 1

In 2019, the annual total compensation of Paul A. Friedman was $6,093,192.

The annual total compensation of the median employee at Synta Pharmaceuticals was $791,000.

The ratio of Paul A. Friedman's pay to the pay of median employee was therefore 8 to one.

Source: SEC filing on April 29, 2020.

Friedman's colleagues

We found four more compensation records of executives who worked with Paul A. Friedman at Synta Pharmaceuticals in 2019.

2019

Rebecca Taub

Synta Pharmaceuticals

Chief Medical Officer

2019

Brian Lynch

Synta Pharmaceuticals

General Counsel

2019

Brian Lynch

Synta Pharmaceuticals

General Counsel

2019

Marc Schneebaum

Synta Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like